rs117114021

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_178452.6(DNAAF1):​c.1300G>A​(p.Gly434Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000528 in 1,583,090 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00051 ( 6 hom. )

Consequence

DNAAF1
NM_178452.6 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 0.00700
Variant links:
Genes affected
DNAAF1 (HGNC:30539): (dynein axonemal assembly factor 1) The protein encoded by this gene is cilium-specific and is required for the stability of the ciliary architecture. It is involved in the regulation of microtubule-based cilia and actin-based brush border microvilli. Mutations in this gene are associated with primary ciliary dyskinesia-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003050983).
BP6
Variant 16-84170128-G-A is Benign according to our data. Variant chr16-84170128-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 416067.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Benign=2, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000657 (100/152162) while in subpopulation EAS AF= 0.0129 (67/5178). AF 95% confidence interval is 0.0105. There are 0 homozygotes in gnomad4. There are 55 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAAF1NM_178452.6 linkc.1300G>A p.Gly434Arg missense_variant Exon 8 of 12 ENST00000378553.10 NP_848547.4 Q8NEP3-1A0A140VJN4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAAF1ENST00000378553.10 linkc.1300G>A p.Gly434Arg missense_variant Exon 8 of 12 1 NM_178452.6 ENSP00000367815.5 Q8NEP3-1

Frequencies

GnomAD3 genomes
AF:
0.000658
AC:
100
AN:
152042
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.0129
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.00129
AC:
323
AN:
251318
Hom.:
1
AF XY:
0.00118
AC XY:
160
AN XY:
135842
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.0147
Gnomad SAS exome
AF:
0.000523
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000238
Gnomad OTH exome
AF:
0.000490
GnomAD4 exome
AF:
0.000514
AC:
736
AN:
1430928
Hom.:
6
Cov.:
96
AF XY:
0.000506
AC XY:
360
AN XY:
711280
show subpopulations
Gnomad4 AFR exome
AF:
0.0000610
Gnomad4 AMR exome
AF:
0.0000921
Gnomad4 ASJ exome
AF:
0.0000807
Gnomad4 EAS exome
AF:
0.0110
Gnomad4 SAS exome
AF:
0.000804
Gnomad4 FIN exome
AF:
0.000151
Gnomad4 NFE exome
AF:
0.000183
Gnomad4 OTH exome
AF:
0.000768
GnomAD4 genome
AF:
0.000657
AC:
100
AN:
152162
Hom.:
0
Cov.:
32
AF XY:
0.000739
AC XY:
55
AN XY:
74402
show subpopulations
Gnomad4 AFR
AF:
0.0000482
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.0129
Gnomad4 SAS
AF:
0.00166
Gnomad4 FIN
AF:
0.000189
Gnomad4 NFE
AF:
0.000279
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000226
Hom.:
0
Bravo
AF:
0.000801
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.00145
AC:
176
EpiCase
AF:
0.000218
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:2
Dec 15, 2020
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
Jul 21, 2019
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

See Variant Classification Assertion Criteria. -

Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

DNAAF1: BP4, BS1 -

Primary ciliary dyskinesia 13 Uncertain:1
Jan 15, 2018
Illumina Laboratory Services, Illumina
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
5.5
DANN
Benign
0.33
DEOGEN2
Benign
0.0048
T
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.0066
N
LIST_S2
Benign
0.53
T
MetaRNN
Benign
0.0031
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.55
N
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-0.48
N
REVEL
Benign
0.0070
Sift
Benign
0.20
T
Sift4G
Benign
0.55
T
Polyphen
0.0010
B
Vest4
0.11
MutPred
0.14
Gain of methylation at K430 (P = 0.1213);
MVP
0.11
MPC
0.021
ClinPred
0.0075
T
GERP RS
-2.6
Varity_R
0.051
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs117114021; hg19: chr16-84203734; COSMIC: COSV100533454; COSMIC: COSV100533454; API